THE SELECTION OF HARD CLINICAL ENDPOINTS VERSUS SURROGATE ENDPOINTS AS THE PRIMARY OUTCOME MEASURE IN MAJOR CARDIOVASCULAR CLINICAL TRIALS IS NOT INFLUENCED BY THE SOURCE OF FUNDING

被引：0
|
作者：
Aneja, Ashish
Esquitin, Ricardo
Shah, Kshitij
Razzouk, Louai
Iyengar, Rupa
Wali, Irfan
Mathew, Verghese
Farkouh, Michael E.
机构：
[1] Case Western Reserve Univ, MetroHlth Med Ctr Campus, Cleveland, OH USA
[2] Mt Sinai Sch Med, New York, NY USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2010年 / 55卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1031-180
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical trials: Surrogate endpoints or hard endpoints?
    Kuller, LH
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (2A): : 59E - 61E
  • [2] Surrogate endpoints in randomized cardiovascular clinical trials
    Domanski, Michael
    Pocock, Stuart
    Bernaud, Corine
    Borer, Jeffrey
    Geller, Nancy
    Revkin, James
    Zannad, Faiez
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (04) : 411 - 413
  • [3] Endpoints in clinical studies:: Surrogate parameters or hard clinical endpoints?
    Böger, RH
    [J]. INTERNIST, 2002, 43 (04): : 493 - 497
  • [4] Surrogate Endpoints in Clinical Trials
    Elliott, Michael R.
    [J]. ANNUAL REVIEW OF STATISTICS AND ITS APPLICATION, 2023, 10 : 75 - 96
  • [5] MAJOR CARDIOVASCULAR TRIALS WITH PRIMARY SURROGATE ENDPOINTS: 2006 TO 2011
    Bikdeli, Behnood
    Punnanithinont, Natdanai
    Shi, Ruizhi
    Ross, Joseph
    Krumholz, Harlan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1585 - E1585
  • [6] The use of surrogate endpoints in clinical trials: focus on clinical trials in cardiovascular diseases
    Lonn, E
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) : 497 - 508
  • [7] SURROGATE ENDPOINTS IN CLINICAL-TRIALS
    FRIEDMAN, L
    YUSUF, S
    [J]. CONTROLLED CLINICAL TRIALS, 1985, 6 (03): : 222 - 222
  • [8] OMARKERS AS SURROGATE ENDPOINTS IN CLINICAL TRIALS
    Rosenkranz, Bernd
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S31 - S32
  • [9] Trends in Utilization of Surrogate Endpoints in Contemporary Cardiovascular Clinical Trials
    Patel, Ravi B.
    Vaduganathan, Muthiah
    Samman-Tahhan, Ayman
    Kalogeropoulos, Andreas P.
    Georgiopoulou, Vasiliki V.
    Fonarow, Gregg C.
    Gheorghiade, Mihai
    Butler, Javed
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (11): : 1845 - 1850
  • [10] Biomarkers and surrogate endpoints in clinical trials
    Fleming, Thomas R.
    Powers, John H.
    [J]. STATISTICS IN MEDICINE, 2012, 31 (25) : 2973 - 2984
12345